results extremely unimpressive squeak says massachusetts psychiatrist daniel carlat editor respected carlat psychiatry report clinician patient family difference abilify took placebo would hard actually see adds dr carlat referring comparison abilify placebo treatment depression topic i discussed depth previously quote comes melissa healy piece los angeles times throws damper abilify parade depression another melissa healy piece la times starts follows year ago patients began trooping office ucla psychiatrist andrew leuchter asking whether antipsychotic drug called abilify might right appeared delusional plagued hallucinations suffering fearsome mood swings mostly depressed anxious frustrated pace recovery leuchter wondered depressed patients usually seek drugs used quell psychiatry disturbing symptoms soon discovered spending new advertising campaign touting abilify add treatment depression first time since arrival new generation antipsychotic medications six drugs called atypicals work differently earlier generation antipsychotic drugs makers one abilify granted legal right market vast new population patients beyond schizophrenia bipolar disorder bristol myers squibb advertisement drug classic bms notes two thirds depressed patients take antidepressants still symptoms course antidepressants point antidepressants ai exactly miracle pills commercial implies abilify must really helpful patients add abilify treatment regimen experience remission depressive symptoms bit strange abilify appealing two thirds patients still depressive symptoms taking antidepressant offering treatment lead remission one quarter course studies compared adding abilify adding another antidepressant adding psychotherapy adding exercise routine adding anything except placebo oh given abilify led remission symptoms patients placebo led remission patients um pretty small difference keep mind studies designed manner almost sure find benefit abilify i noted previously abilify generally benign relatively small benefit placebo acceptable i mentioned previously side effects troubling i took issue bms funded journal article puff piece tried spin side effect data abilify authors note adjunctive aripiprazole relatively well tolerated patients mdd relatively relative hit baseball bat repeatedly note akathisia occurred patients abilify compared patients placebo restlessness vs insomnia vs fatigue vs blurred vision vs authors report akathisia resolved patients end study would also mean patients akathisia stuck end study worry relatively well tolerated got ta like drug induces akathisia rate induces symptom remission psychiatrist doug bremner similar take abilify showing poor cost benefit ratio descriptions akathisia see comments post furious seasons given unimpressive scientific data regarding abilify depression one hand drug exploding sales i sure glad see big paper la times note really controversy seroquel receives official fda approval add treatment depression get ready marketing machine reach fever pitch viva zyprexa anyone melissa healy covers expansion atypical antipsychotics schizophrenia bipolar disorder depression article y'all simply must read i close sad true quote yale psychiatry professor robert rosenheck story pretty clear pretty embarrassing profession psychiatry allowed led marketing says robert rosenheck psychiatrist yale university studied effectiveness expanded use atypical antipsychotics know companies strategies number people schizophrenia limited road profitability goes soccer moms need market drugs ordinary people dissatisfactions life